*ST Spring: Received inquiry letter from Shanghai Stock Exchange regarding 2025 annual report

ST ChunTian announced that it has recently received an inquiry letter from the Shanghai Stock Exchange regarding the 2025 annual report of Qinghai ChunTian Medicinal Resources Technology Co., Ltd., involving four main points. Firstly, the compliance of revenue recognition in the liquor business. Secondly, the operation of the caterpillar fungus business, including the reasons for the revenue growth in the fourth quarter. Thirdly, matters related to prepayment of related party funds, such as the situation of recovering 100 million yuan of prepaid investment funds. Fourthly, other matters including long-term equity investments, intangible assets, inventory, etc. The company is required to provide a written reply within 10 trading days and fulfill its disclosure obligations.